Sorriso Pharmaceuticals

Developer of disease-modifying antibodies designed for the treatment of inflammatory diseases, including Crohn's disease and ulcerative colitis. The company develops potent antibodies that can be deli...

Healthcare
Sandy, UT, United States
Founded 2020
8 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$31M
Last Round
N/A

Get the full picture

Create a free account to unlock Sorriso Pharmaceuticals's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required